Convection-enhanced delivery
Showing 1 - 25 of >10,000
Gliomas Trial in New York (Topotecan, Gadolinium, Synchromed II infusion pumps)
Completed
- Gliomas
- Topotecan
- +2 more
-
New York, New YorkColumbia University Irving Medical Center
Jun 30, 2022
Glioma, Malignant, High Grade Glioma, Glioblastoma Trial in Tampa (OS2966, Gadoteridol)
Active, not recruiting
- Glioma, Malignant
- +4 more
-
Tampa, FloridaMoffitt Cancer Center
Nov 28, 2022
Parkinson's Disease Trial run by the National Institute of Neurological Disorders and Stroke (NINDS) (Convection enhanced
Completed
- Parkinson's Disease
- Convection enhanced delivery/AAV2-GDNF
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Diffuse Intrinsic Pontine Glioma Trial in San Francisco (Panobinostat Nanoparticle Formulation MTX110, Convection-Enhanced
Completed
- Diffuse Intrinsic Pontine Glioma
- Panobinostat Nanoparticle Formulation MTX110
- Convection-Enhanced Delivery (CED)
-
San Francisco, CaliforniaUniversity of California, San Francisco
Feb 2, 2022
DIPG Trial (131I-Omburtamab, Convention Enhanced Delivery)
Not yet recruiting
- DIPG
- 131I-Omburtamab
- Convention Enhanced Delivery
- (no location specified)
Feb 7, 2022
Mesial Temporal Lobe Epilepsy Trial in Columbus (AAV9-hSyn1-miGRIK2)
Not yet recruiting
- Mesial Temporal Lobe Epilepsy
- AAV9-hSyn1-miGRIK2
-
Columbus, OhioOhio State University
Sep 25, 2023
Diffuse Intrinsic Pontine Glioma, Diffuse Pontine and Thalamic Gliomas, Diffuse Midline Glioma Trial in New York (Infusate with
Recruiting
- Diffuse Intrinsic Pontine Glioma
- +2 more
- Infusate with MTX110 and gadolinium
- Convection-Enhanced Delivery (CED)
-
New York, New YorkColumbia University Irving Medical Center
Mar 8, 2022
Malignant Glioma Trial in Durham (D2C7-IT (6920 ng/mL via convection-enhanced delivery), Atezolizumab (1200 mg every three
Recruiting
- Malignant Glioma
- D2C7-IT (6920 ng/mL via convection-enhanced delivery)
- +2 more
-
Durham, North CarolinaDuke University Medical Center
Mar 22, 2022
Malignant Glioma, Brain Tumor, Recurrent Trial in Durham (D2C7-IT)
Active, not recruiting
- Malignant Glioma
- Brain Tumor, Recurrent
-
Durham, North CarolinaPreston Robert Tisch Brain Tumor Center at Duke
Jul 12, 2022
High Grade Glioma Trial in San Francisco (nanoliposomal irinotecan)
Active, not recruiting
- High Grade Glioma
- nanoliposomal irinotecan
-
San Francisco, CaliforniaUniversity of California, San Francisco
Oct 26, 2021
Parkinson Disease Trial in Charlottesville (Intracerebral Infusion of Autologous Cerebral Spinal Fluid)
Completed
- Parkinson Disease
- Intracerebral Infusion of Autologous Cerebral Spinal Fluid
-
Charlottesville, VirginiaUniversity of Virginia
Mar 16, 2021
The Aim of Our Study Was to Evaluate the Outcomes in Women Who Implemented the Enhanced Recovery After Surgery Protocol at
Completed
- The Aim of Our Study Was to Evaluate the Outcomes in Women Who Implemented the Enhanced Recovery After Surgery Protocol at Delivery by Cesarean Delivery
-
Düzce, TurkeyAli Yavuzcan
Apr 23, 2023
Perinatal Death Trial in Karachi (Enhanced Delivery and Newborn kit)
Recruiting
- Perinatal Death
- Enhanced Delivery and Newborn kit
-
Karachi, Sindh, PakistanAga Khan University
Nov 28, 2022
Capsule Endoscopy Delivery at sCale Through Enhanced AI anaLysis
Recruiting
- Bowel Cancer
-
Coventry, United KingdomUniversity Hospitals Coventry and Warwickshire
Aug 21, 2023
Diabetes, Type 2 Trial (Digital Health Coaching, Food Box Delivery, Remote Patient Monitoring (RPM))
Recruiting
- Diabetes Mellitus, Type 2
- Digital Health Coaching
- +3 more
-
Birmingham, AlabamaUAB Hospital-Highlands
Feb 2, 2023
Recurrent High Grade Glioma Trial (MVR-C5252)
Not yet recruiting
- Recurrent High Grade Glioma
- MVR-C5252
- (no location specified)
Nov 6, 2023
Breast Cancer Trial (Early Point-of-Service Social and Behavioral Determinants of Health (SBDOH) Screening)
Not yet recruiting
- Breast Cancer
- Early Point-of-Service Social and Behavioral Determinants of Health (SBDOH) Screening
- (no location specified)
Sep 5, 2023
Heart Failure Trial in Uganda (Enhanced HF Clinical Care (Core-HF), Digital health intervention (Medly Uganda) plus enhanced HF
Not yet recruiting
- Heart Failure
- Enhanced HF Clinical Care (Core-HF)
- Digital health intervention (Medly Uganda) plus enhanced HF clinical care (Core-HF)
-
Fort Portal, Uganda
- +5 more
Jul 13, 2023
Obesity Trial in Lexington, Chapel Hill (Enhanced Go NAPSACC, Basic Go NAPSACC)
Active, not recruiting
- Obesity
- Enhanced Go NAPSACC
- Basic Go NAPSACC
-
Lexington, Kentucky
- +1 more
Oct 25, 2022
Cognitive Decline, Hypertension, Diet Trial (Enhanced Usual Care (EUC), Food Delivery and Cooking PLUS Aerobic Training
Not yet recruiting
- Cognitive Decline
- +3 more
- Enhanced Usual Care (EUC)
- Food Delivery and Cooking PLUS Aerobic Training (FoRKS+)
- (no location specified)
Nov 20, 2023
Vitiligo Trial in Tel Aviv (Enhanced Transcutaneous Delivery of Topical Betamethasone after the treatment with Tixel, Topical
Recruiting
- Vitiligo
- Enhanced Transcutaneous Delivery of Topical Betamethasone after the treatment with Tixel
- Topical treatment
-
Tel Aviv, IsraelDepartment of Dermatology, Tel Aviv Sourasky medical center
Feb 9, 2022